« Return to News | CROs/Service Providers

Kendle Opens New Operations Center in India

Monday, June 28, 2010 09:03 AM

Global contract research organization Kendle has opened its new operations center in the special economic zone (SEZ) of the Ahmedabad-Gandhinagar Knowledge Corridor. The new SEZ center represents a strategic investment for Kendle and demonstrates the company's commitment to further invest in Asia/Pacific region.

The SEZ operations center will focus on delivery of clinical data management, medical writing, pharmacovigilance/safety, biostatistics/programming and other knowledge processing-related services. Kendle's SEZ operations center will initially employ approximately 50 professionals at the site and is expected to scale up to 300 associates in the near term.

"Growth in India is a key component of our strategy and will be very important to the future of Kendle," said Stephen Cutler, senior vice president and chief operating officer. "Our expanded presence in Asia, and in India in particular, creates efficiencies in the clinical development process for our customers worldwide and positions Kendle as a leading provider of high-quality, innovative and cost-effective clinical development services in this growing market."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.